Early ribavirin treatment of respiratory syncytial viral infection in high-risk children

Clicks: 347
ID: 120484
1990
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
A 3-year prospective, blinded, multicenter study was done to assess the efficacy of early ribavirin intervention in mild respiratory syncytial virus illness in children with bronchopulmonary dysplasia or with congenital heart disease. A cohort of 178 children younger than 36 months of age with bronc …
Reference Key
jr1990theearly Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Groothuis JR;Woodin KA;Katz R;Robertson AD;McBride JT;Hall CB;McWilliams BC;Lauer BA;;
Journal the journal of pediatrics
Year 1990
DOI DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/2231215
Keywords
respiration National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't u.s. gov't female male Child Infant Comparative Study Prospective Studies newborn P.H.S. preschool Clinical Trial Double-Blind Method Multicenter Study oximetry respirovirus infections / physiopathology time factors controlled clinical trial ribavirin / administration & dosage ribavirin / therapeutic use* respirovirus infections / drug therapy* respiratory syncytial viruses* heart defects respirovirus infections / complications j r groothuis bronchopulmonary dysplasia / complications congenital / complications pmid:2231215 doi:10.1016/s0022-3476(05)83347-5 k a woodin b a lauer

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.